Research Article
Clinical Profile and Visual Outcome of Ocular Bartonellosis in Malaysia
Table 2
Ocular Presentation of Bartonellosis and Treatment Regime.
| | Case number | Lat | Initial VA | Final VA | Positive serology (titre) | Anterior
uveitis | Neuroretinitis | Optic disc
edema | Others | Rx | Corticosteroid therapy |
| | (1) | B | RE 6/18 LE 6/24 | RE 6/7.5 LE 6/7.5 | Ig M (1 : 96)
/Ig G (1 : 56) | | Yes | | | Azi | Oral | | (2) | R | 6/120 | 6/21 | Ig M (1 : 24)
/Ig G (1 : 128) | Yes | Yes | | | Azi | IV then oral | | (3) | R | 6/24 | 6/6 | Ig M (n/a)
/Ig G (n/a) | | | Yes | Focal choroiditis | Azi | None | | (4) | L | 6/120 | 6/45 | Ig M (1 : 24)
/Ig G (1 : 128) | | | Yes | Retinal infiltrates | Azi | Oral | | (5) | L | 6/7.5 | 6/6 | Ig M (1 : 48)
/Ig G (1 : 256) | | | Yes | | Azi | None | | (6) | L | 2/60 | 6/6 | Ig M/(1 : 24)
/Ig G (1 : 128) | Yes | Yes | | CWS | Azi | Topical | | (7) | B | RE 6/30 LE 6/21 | RE 6/9 LE 6/6 | Ig M/(1 : 48)
/Ig G (1 : 128) | | Yes | | | Cip | IV only | | (8) | B | RE 6/7.5 LE 6/12 | RE 6/7.5 LE 6/7.5 | Ig G (1 : 128) | | Yes | | | Dox | None | | (9) | L | 6/24 | LE 6/6 | Ig M (1 : 24)
/Ig G (1 : 128) | | | Yes | | Dox | Topical | | (10) | B | RE 6/6 LE 6/6 | RE 6/6 LE 6/6 | Ig M (1 : 24)
/Ig G (1 : 128) | Yes | | Yes | | None | None | | (11) | B | RE 6/6 LE 2/60 | RE 6/6 LE 6/9 | Ig M (1 : 96)
/Ig G (1 : 512) | | Yes | | Retinal infiltrates | Azi | Oral | | (12) | B | RE CF LE 6/36 | RE 6/9 LE 6/6 | Ig G (1 : 128) | | Yes | | CWS/retinal hemorrhage | Ceft | None | | (13) | B | RE 6/9 LE 6/60 | RE 6/9 LE 6/24 | Ig G (1 : 128) | | | Yes | | Ceft/Azi | IV then oral | | (14) | L | 1/60 | 6/24 | Ig M (1 : 24)
/Ig G (1 : 128) | | Yes | | | Cefu | Oral | | (15) | R | HM | HM | Ig M (1 : 24)
/Ig G (1 : 128) | | | Yes | Macular edema/
vasculitis/dilated vessels/retinal hemorrhage | Ceft/Dox | IV then oral | | (16) | L | 6/60 | 6/36 | Ig M (1 : 24)
/Ig G (1 : 128) | | Yes | | | Dox | IV then oral | | (17) | L | 6/18 | 6/9 | Ig G (1 : 128) | | | Yes | Vasculitis/
dilated vessels/
perivascular sheathing | Co-t | Oral | | (18) | R | 6/9 | 6/6 | Ig G (1 : 128) | Yes | | | | Ceft/Cefu | Topical | | (19) | L | 6/24 | 6/6 | Ig G (1 : 128) | Yes | Yes | | Retinal hemorrhage | None | IV then oral |
|
|
Lat, laterality; R, right; L, left; B, bilateral; VA: visual acuity; CF, counting finger; HM, hand movement; Ig, immunoglobulin; Rx, antibiotic; Azi, azithromycin; Cip, ciprofloxacin; Dox, doxycycline; Ceft, ceftazidime; Cefu, cefuroxime; Co-t, cotrimoxazole; IV, intravenous.
|
